Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Trachoma: protective and pathogenic ocular immune responses to Chlamydia trachomatis.

Hu VH, Holland MJ, Burton MJ.

PLoS Negl Trop Dis. 2013;7(2):e2020. doi: 10.1371/journal.pntd.0002020. Epub 2013 Feb 14. Review.

2.

Innate immune responses and modified extracellular matrix regulation characterize bacterial infection and cellular/connective tissue changes in scarring trachoma.

Hu VH, Weiss HA, Ramadhani AM, Tolbert SB, Massae P, Mabey DC, Holland MJ, Bailey RL, Burton MJ.

Infect Immun. 2012 Jan;80(1):121-30. doi: 10.1128/IAI.05965-11. Epub 2011 Oct 28.

3.

Conjunctival FOXP3 expression in trachoma: do regulatory T cells have a role in human ocular Chlamydia trachomatis infection?

Faal N, Bailey RL, Jeffries D, Joof H, Sarr I, Laye M, Mabey DC, Holland MJ.

PLoS Med. 2006 Aug;3(8):e266.

4.

T helper type-1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PBMC); responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring.

Holland MJ, Bailey RL, Conway DJ, Culley F, Miranpuri G, Byrne GI, Whittle HC, Mabey DC.

Clin Exp Immunol. 1996 Sep;105(3):429-35.

5.

Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.

Roberts CH, Molina S, Makalo P, Joof H, Harding-Esch EM, Burr SE, Mabey DC, Bailey RL, Burton MJ, Holland MJ.

PLoS Negl Trop Dis. 2014 Mar 20;8(3):e2744. doi: 10.1371/journal.pntd.0002744. eCollection 2014 Mar.

6.

Delivery of a Chlamydial Adhesin N-PmpC Subunit Vaccine to the Ocular Mucosa Using Particulate Carriers.

Inic-Kanada A, Stojanovic M, Schlacher S, Stein E, Belij-Rammerstorfer S, Marinkovic E, Lukic I, Montanaro J, Schuerer N, Bintner N, Kovacevic-Jovanovic V, Krnjaja O, Mayr UB, Lubitz W, Barisani-Asenbauer T.

PLoS One. 2015 Dec 11;10(12):e0144380. doi: 10.1371/journal.pone.0144380. eCollection 2015.

7.

Inverse relationship between microRNA-155 and -184 expression with increasing conjunctival inflammation during ocular Chlamydia trachomatis infection.

Derrick T, Last AR, Burr SE, Roberts CH, Nabicassa M, Cassama E, Bailey RL, Mabey DC, Burton MJ, Holland MJ.

BMC Infect Dis. 2016 Feb 3;16:60. doi: 10.1186/s12879-016-1367-8.

8.

Towards a safe and effective chlamydial vaccine: lessons from the eye.

Mabey DC, Hu V, Bailey RL, Burton MJ, Holland MJ.

Vaccine. 2014 Mar 20;32(14):1572-8. doi: 10.1016/j.vaccine.2013.10.016. Review.

9.

Role of secreted conjunctival mucosal cytokine and chemokine proteins in different stages of trachomatous disease.

Skwor TA, Atik B, Kandel RP, Adhikari HK, Sharma B, Dean D.

PLoS Negl Trop Dis. 2008 Jul 16;2(7):e264. doi: 10.1371/journal.pntd.0000264.

10.

Intramuscular Immunisation with Chlamydial Proteins Induces Chlamydia trachomatis Specific Ocular Antibodies.

Badamchi-Zadeh A, McKay PF, Holland MJ, Paes W, Brzozowski A, Lacey C, Follmann F, Tregoning JS, Shattock RJ.

PLoS One. 2015 Oct 26;10(10):e0141209. doi: 10.1371/journal.pone.0141209. eCollection 2015.

11.

Pathogenesis of progressive scarring trachoma in Ethiopia and Tanzania and its implications for disease control: two cohort studies.

Burton MJ, Rajak SN, Hu VH, Ramadhani A, Habtamu E, Massae P, Tadesse Z, Callahan K, Emerson PM, Khaw PT, Jeffries D, Mabey DC, Bailey RL, Weiss HA, Holland MJ.

PLoS Negl Trop Dis. 2015 May 13;9(5):e0003763. doi: 10.1371/journal.pntd.0003763. eCollection 2015 May.

12.

Transcriptional profiling of human epithelial cells infected with plasmid-bearing and plasmid-deficient Chlamydia trachomatis.

Porcella SF, Carlson JH, Sturdevant DE, Sturdevant GL, Kanakabandi K, Virtaneva K, Wilder H, Whitmire WM, Song L, Caldwell HD.

Infect Immun. 2015 Feb;83(2):534-43. doi: 10.1128/IAI.02764-14. Epub 2014 Nov 17.

13.

Innate immunity in ocular Chlamydia trachomatis infection: contribution of IL8 and CSF2 gene variants to risk of trachomatous scarring in Gambians.

Natividad A, Hull J, Luoni G, Holland M, Rockett K, Joof H, Burton M, Mabey D, Kwiatkowski D, Bailey R.

BMC Med Genet. 2009 Dec 16;10:138. doi: 10.1186/1471-2350-10-138.

14.

Multiple Chlamydiaceae species in trachoma: implications for disease pathogenesis and control.

Dean D, Kandel RP, Adhikari HK, Hessel T.

PLoS Med. 2008 Jan 3;5(1):e14. doi: 10.1371/journal.pmed.0050014.

15.

Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease.

Beatty WL, Byrne GI, Morrison RP.

Trends Microbiol. 1994 Mar;2(3):94-8. Review.

PMID:
8156277
16.

Antibody signature of spontaneous clearance of Chlamydia trachomatis ocular infection and partial resistance against re-challenge in a nonhuman primate trachoma model.

Kari L, Bakios LE, Goheen MM, Bess LN, Watkins HS, Southern TR, Song L, Whitmire WM, Olivares-Zavaleta N, Caldwell HD.

PLoS Negl Trop Dis. 2013 May 30;7(5):e2248. doi: 10.1371/journal.pntd.0002248. Print 2013.

17.

Conjunctival scarring in trachoma is associated with depressed cell-mediated immune responses to chlamydial antigens.

Holland MJ, Bailey RL, Hayes LJ, Whittle HC, Mabey DC.

J Infect Dis. 1993 Dec;168(6):1528-31.

PMID:
8245540
18.

CD8+ T cells define an unexpected role in live-attenuated vaccine protective immunity against Chlamydia trachomatis infection in macaques.

Olivares-Zavaleta N, Whitmire WM, Kari L, Sturdevant GL, Caldwell HD.

J Immunol. 2014 May 15;192(10):4648-54. doi: 10.4049/jimmunol.1400120. Epub 2014 Apr 7.

19.

Trachoma: an overview.

Burton MJ.

Br Med Bull. 2007;84:99-116. doi: 10.1093/bmb/ldm034. Epub 2008 Jan 5. Review.

PMID:
18175788
20.

Trachoma and Ocular Chlamydial Infection in the Era of Genomics.

Derrick T, Roberts Ch, Last AR, Burr SE, Holland MJ.

Mediators Inflamm. 2015;2015:791847. doi: 10.1155/2015/791847. Epub 2015 Sep 3. Review.

Supplemental Content

Support Center